XML 22 R104.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule 1 - Condensed Financial Information of Registrant Orthofix International NV - Condensed Statement of Cash Flows (unaudited) (Detail) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Condensed Financial Statements, Captions [Line Items]      
Net income (loss) $ (25,515) $ 42,838 $ (18,110)
Cash flows from investing activities:      
Capital expenditures (24,787) (27,994) (24,965)
Cash flows from financing activities:      
Net proceeds from issuance of common stock 3,450 25,586 20,113
Contributions to subsidiaries and affiliates     (517)
Tax benefit on exercise of stock options 82 1,020 1,737
Cash and cash equivalents at the beginning of the year 31,055 33,207 13,561
Cash and cash equivalents at the end of the year 30,486 31,055 33,207
Orthofix International N V [Member]
      
Condensed Financial Statements, Captions [Line Items]      
Net income (loss) (25,515) 42,838 (18,110)
Equity in earnings of (loss) investments in subsidiaries and affiliates 9,197 (50,317) 6,296
Cash used in provided by other operating activities 468 (6,811) 3,429
Net cash used in operating activities (15,850) (14,290) (8,385)
Cash flows from investing activities:      
Distributions and amounts received from subsidiaries 53,389 12,564 5,875
Capital expenditures         
Net cash used in provided by investing activities 53,389 12,564 5,875
Cash flows from financing activities:      
Net proceeds from issuance of common stock 3,450 25,586 20,113
Repurchase of treasury shares (39,494)      
Contributions to subsidiaries and affiliates (7,543) (36,921) (2,789)
Tax benefit on exercise of stock options 82 1,020 1,737
Net cash provided by financing activities (43,505) (10,315) 19,061
Net increase (decrease) in cash and cash equivalents (5,966) (12,041) 16,551
Cash and cash equivalents at the beginning of the year 7,392 19,433 2,882
Cash and cash equivalents at the end of the year $ 1,426 $ 7,392 $ 19,433